Selected Publications

Saleem, A., Harte, R.J., Matthews, J.C., Osman, S., Brady, F., Luthra, S., Brown, G., Bleehen, N., Connors, T., Jones, T., Price, P. and Aboagye, E. (2001). Pharmacokinetic evaluation of N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (DACA; XR5000) in patients by positron emission tomography (PET). J Clin Oncol 19(5): 1421-1429.

Aboagye, E., Saleem, A., Cunningham, V.J., Osman, S. and Price, P. (2001). Extraction of 5-Fluorouracil by Tumor and Liver: a Noninvasive Positron Emission Tomography Study of Patients with Gastrointestinal Cancer. Cancer Research 61: 4937-4941.

Osman, S., Rowlinson-Busza, G., Luthra, S., Aboagye, E., Brown, G., Brady, F., Myers, R., Gamage, S.A., Denny, W.A., Baguely, B. and Price, P. (2001). Comparative Biodistribution and Metabolism of carbon-11 labelled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, DACA, and DNA-Intercalation Analogues. Cancer Research 61: 2935-2944.

Saleem A, Yapp J, Osman S, Brady F, Suttle B, Lucase SV, Jones T, Price P and Aboagye EO.¿ Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in vivo imaging of drug action.¿ Lancet (2000) 355, 2125-31

Brock CS, Young H, O'Reilly SM et al. Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas. Br J Cancer, 2000; 82(3): 608-15